Actinium Pharmaceuticals, Inc. (ATNM)
1.18
-0.05
(-4.06%)
USD |
NYAM |
Mar 05, 16:00
1.19
+0.01
(+0.85%)
After-Hours: 20:00
Actinium Pharmaceuticals Cash from Investing (TTM) : 0.00 for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Assertio Holdings, Inc. | -12.57M |
| Altimmune, Inc. | -- |
| Aldeyra Therapeutics, Inc. | 47.74M |
| Avanos Medical, Inc. | -60.60M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |